Similar articles

• P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.

  von Kügelgen I, Stoffel D, Starke K. von Kügelgen I, et al. Br J Pharmacol. 1995 May;115(2):247-54. doi: 10.1111/j.1476-5381.1995.tb15870.x. Br J Pharmacol. 1995. PMID: 7670726 Free PMC article.
• Failure of presynaptic purinoceptors to modulate noradrenaline release from sympathetic nerves in human dental pulp.

  Parker DA, Marino V, Krishna M, Narayanan A, de la Lande IS. Parker DA, et al. Arch Oral Biol. 2000 Oct;45(10):827-31. doi: 10.1016/s0003-9969(00)00059-5. Arch Oral Biol. 2000. PMID: 10973556
• Purines and pain mechanisms: recent developments.

  Liu XJ, Salter MW. Liu XJ, et al. Curr Opin Investig Drugs. 2005 Jan;6(1):65-75. Curr Opin Investig Drugs. 2005. PMID: 15675605 Review.
• P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens.

  Driessen B, von Kügelgen I, Starke K. Driessen B, et al. Naunyn Schmiedebergs Arch Pharmacol. 1994 Jul;350(1):42-8. doi: 10.1007/BF00180009. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7935853
• Purinergic signaling in the inner ear.

  Lee JH, Marcus DC. Lee JH, et al. Hear Res. 2008 Jan;235(1-2):1-7. doi: 10.1016/j.heares.2007.09.006. Epub 2007 Sep 29. Hear Res. 2008. PMID: 17980525 Free PMC article. Review.